Apogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 5,500 Shares
Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $134.17, for a total value of $737,935.00. Following the completion of the transaction, the insider owned 168,498 shares of […]
Atul Dandekar Sells 7,500 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) insider Atul Dandekar sold 7,500 shares of the stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $27.34, for a total value of $205,050.00. Following the sale, the insider directly owned 26,250 shares of the company’s stock, valued at […]
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $89,942.86 in Stock
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) insider Gwenn Hansen sold 3,847 shares of the company’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $23.38, for a total value of $89,942.86. Following the completion of the sale, the insider owned 121,338 shares in […]
Viking Therapeutics (NASDAQ:VKTX) CEO Brian Lian Sells 148,517 Shares of Stock
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) CEO Brian Lian sold 148,517 shares of the stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $33.32, for a total transaction of $4,948,586.44. Following the sale, the chief executive officer owned 2,572,441 shares of the company’s stock, valued […]
MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Kristian Reich Sells 1,100 Shares of Stock
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) insider Kristian Reich sold 1,100 shares of the business’s stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $20.00, for a total value of $22,000.00. Following the sale, the insider directly owned 2,711,198 shares of the company’s stock, valued at […]
Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 16,667 Shares
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) insider Amy Simon sold 16,667 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $25.74, for a total transaction of $429,008.58. Following the sale, the insider directly owned 85,696 shares in the company, […]
last updated on 8 Aug 02:50